Disease Specific FISH Probe
-
Price:
Negotiable
- minimum:
- Total supply:
-
Delivery term:
The date of payment from buyers deliver within days
-
seat:
Hubei
-
Validity to:
Long-term effective
-
Last update:
2020-02-29 10:59
-
Browse the number:
158
+
- Contactaixin:
kanglu(Mr.)
- Email: telephone: phone:
-
Arrea:
Hubei
Address:No. 666 Gaoxin Boulevard, Biolake, Bldg B6, 4/5F. 430075 Wuhan, Hubei, China.
-
Website:
http://www.health-carebiotech.com/ http://kanglu.zjjcyy.com/
+
"Disease specific probe is a kind of molecular diagnostic reagent. Specific genes related to specific diseases are labeled with green or orange fluorescence and hybridized with corresponding gene loci. By observing the fluorescent signal points and identify the status of the signal points,the results can provide the basis for the diagnosis, medication guidance and tumor prognosis.
In different tumors, specific genes may have abnormalities, including gene breakage, gene amplification, gene deletion and so on. DNA probes can detect these abnormalities through labeled fluorescent signal points.
There are two kinds of disease-specific probes: monochrome and bicolor. Our FISH probes are more time-saving, specific and anti quenching.
FISH Probe Name |
Marker Site |
FISH Probe Name |
Marker Site |
|
Non-Small Cell Lung Cancer | Acute Myeloid Leukemia /AML (Non APL) | |||
2p23.1-23.2 |
8q21.3-22.1 21q22.11-22.12 |
|||
7q31.2 | 15q24.1, 17q21.1-21.2 |
|||
7q31.2 | 16q22.1 | |||
11q23.3 | ||||
Breast Cancer | 16q22.1 | |||
17q12-21.1 | ||||
Acute Lymphoblastic Leukemia (ALL) | ||||
Stomach Cancer | 12p13.2, 21q22.11-22.12 |
|||
17q12-21.1 | 9q34.11-13, 22q11.22-23 |
|||
|
14q32.33 | |||
Bladder Cancer | 9p21.3 | |||
9p21.3 | 11q23.3 | |||
|
17q13.1 | centromeric | ||
centromeric | ||||
Cervical Cancer | 8q24 | |||
3q26.2 | ||||
Multiple Myeloma (MM) | ||||
Brain Tumor | 13q14.2 | |||
7q34 |
1q21 | |||
1p/19q FISH probe |
1p36.31, 1q25.3 19q13, 19p13 |
17q13.1 | ||
14q32.33 | ||||
Lymphoma | 11q13.3;14q32.33 |
|||
3q27.3-28 | 13q14.2;13q34 |
|||
18q21.33-22.1 | ||||
|
14q32.33 |
Myelodysplastic Syndrome (MDS) | ||
8q24.21 14q32.33 |
7q31,20q12,5p15 CEPX.CEPY |
|||
18q21.33;14q32.33 |
centromeric | |||
|
17q13.1 | |||
|
8q24.21 | Aplastic Anemia | ||
11q13.3;14q32.33 |
centromeric | |||
7q22.1-22.2;7q31 |
||||
Chronic Lymphocytic Leukemia (CLL) |
|
20q12;20q13.12 |
||
13q14.2, 11q22.3,17q13.1 |
||||
centromeric | Chronic Myeloid Leukemia (CML) | |||
11q22.3 | 9q34.11-13;22q11.22-23 |
|||
13q14.2;13q34 |
||||
6q23.2-23.3 |
Inquiry:
http://www.health-carebiotech.com/